New drug shows promise for leukemia patients with hidden cancer cells
NCT ID NCT05456698
First seen Nov 18, 2025 · Last updated May 11, 2026 · Updated 27 times
Summary
This study tests a drug called inotuzumab ozogamicin in adults with a type of leukemia (Ph-negative ALL) who still have tiny amounts of cancer cells left after initial chemotherapy. The goal is to see if the drug can wipe out those leftover cells. About 31 participants will receive the drug, and researchers will check for complete clearance of the hidden cancer cells.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institute of Hematology & Blood Diseases Hospital
Tianjin, Tianjin Municipality, China
Conditions
Explore the condition pages connected to this study.